Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nai-Wen Su, Chung-Ji Liu, Yi-Shing Leu, Jehn-Chuan Lee, Yu-Jen Chen & Yi-Fang Chang. (2015) Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients. OncoTargets and Therapy 8, pages 251-258.
Read now
Read now
Articles from other publishers (6)
Nai-Wen Su, Kaun-Jer Tsai, Yi-Shing Leu, Jehn-Chuan Lee, Chung-Ji Liu, Chieh-Yuan Cheng, Jiun-Sheng Lin, Yu-Jen Chen, Shih-Hua Liu, Chun-How Chen & Yi-Fang Chang. (2020) Modified 3-weekly cisplatin or cisplatin-5-fluorouracil 5-day infusion as the concurrent chemoradiotherapy regimen in locally advanced squamous cell carcinoma of the head and neck: Comparison of efficacy and toxicity. Journal of Cancer Research and Practice 7:1, pages 17.
Crossref
Crossref
Hiroshi Okuda, Masami Ohnishi, Hiroki Takahashi, Chiaki Takagi, Natsuki Takada & Toshimitsu Ohashi. (2019) Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma. Auris Nasus Larynx 46:6, pages 882-888.
Crossref
Crossref
Gauri Misra, Shipra Gupta & Neetu Jabalia. (2016) Understanding the Interactions of High-Mobility Group of Protein Domain B1 with DNA Adducts Generated by Platinum Anticancer Molecules Using In Silico Approaches. Interdisciplinary Sciences: Computational Life Sciences 10:3, pages 476-485.
Crossref
Crossref
Yongqing Liu, Chunwen Yue, Juan Li, Jing Wu, Shikang Wang, Deqing Sun, Yanxia Guo, Zhaomin Lin, Denglu Zhang & Rongmei Wang. (2017) Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells. Oncology Letters.
Crossref
Crossref
Dirk Rades, Primoz Strojan, Daniel Seidl, Stefan Janssen, Amira Bajrovic, Nadja Kazic, Samer G. Hakim, Barbara Wollenberg & Steven E. Schild. (2016) Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks. Journal of Cranio-Maxillofacial Surgery 44:9, pages 1436-1440.
Crossref
Crossref
David Zaboli, Marietta Tan, Hrishikesh Gogineni, Spencer Lake, Katherine Fan, Marianna L. Zahurak, Barbara Messing, Karen Ulmer, Eva S. Zinreich, Marshall A. Levine, Mei Tang, Sara I. Pai, Ray G. Blanco, John R. Saunders, Simon R. Best, Joseph A. Califano & Patrick K. Ha. (2012) Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients. International Journal of Otolaryngology 2012, pages 1-10.
Crossref
Crossref